BRIX1

BRIX1 is a nucleolar protein essential for biogenesis of the large (60S) ribosomal subunit, a function conserved from yeast to humans (PMID:11843177, PMID:12702244). It binds large-subunit rRNAs (5S, 5.8S, and 28S) and supports pre-rRNA processing and 60S assembly; loss of the yeast ortholog Brx1p blocks large-subunit assembly, and BRIX1 depletion in human cells reduces rRNA levels and nascent rRNA synthesis (PMID:11843177, PMID:38282151). Mechanistically, BRIX1 facilitates formation of the PeBoW complex during pre-rRNA processing (PMID:39475053) and localizes to the nucleolus where it interacts with the rDNA transcription factors UBTF and POLR1A to drive rDNA transcription and global protein translation (PMID:41370029). Through this control of ribosome output, BRIX1 acts as an oncoprotein: it dampens p53 activation by impairing MDM2 interactions with ribosomal proteins RPL5 and RPL11, so that BRIX1 depletion provokes nucleolar stress, RPL5/RPL11-dependent p53 activation, and tumor suppression (PMID:39475053). BRIX1 further sustains malignant phenotypes by selective translational upregulation of the glucose transporter GLUT1 to enhance glycolysis (PMID:38282151) and by supporting SRSF1-mediated oncogenic alternative splicing that produces carcinogenic MKNK2 and S6K1 isoforms feeding mTORC1-4EBP1 signaling (PMID:41370029). BRIX1 expression is itself wired into oncogenic signaling, being transcriptionally activated by mTORC1-SP1 in hepatocellular carcinoma (PMID:41370029) and regulated downstream of AR-ERK signaling in bladder cancer (PMID:33652650).

1. 2001 High

   Established that BRIX1 is a conserved nucleolar factor physically engaged with large ribosomal subunit rRNAs and functionally required for their assembly, defining its founding role in 60S biogenesis.

   Evidence GFP-fusion localization in HeLa and Xenopus, rRNA immunoprecipitation, and conditional depletion of the yeast ortholog Brx1p with ribosome profiling

   PMID:11843177

   Open questions at the time

   • Did not define which rRNA processing step BRIX1 acts on
   • No structural basis for rRNA binding
   • Human loss-of-function phenotype not addressed
2. 2001 Low

   Proposed a shared globular Brix domain across a protein superfamily, framing a unified hypothesis of rRNA binding and ribosome biogenesis function.

   Evidence Sequence homology and domain architecture analysis (bioinformatic only)

   PMID:11406393

   Open questions at the time

   • Computational prediction without experimental RNA-binding validation
   • No functional test of the proposed domain in this work
3. 2003 High

   Showed that BRIX1 belongs to a functionally coherent set of nucleolar large-subunit assembly factors, generalizing its role across the Brix superfamily through genetic epistasis.

   Evidence Conditional alleles, ribosome profiling, and a shared multicopy suppressor screen across four yeast family members

   PMID:12702244

   Open questions at the time

   • Did not resolve distinct molecular substeps for each family member
   • Human paralog functions not tested
4. 2005 Medium

   Provided a structural framework for how Brix-domain proteins might bind RNA, revealing an internally duplicated fold related to aminoacyl-tRNA synthetase anticodon-binding domains.

   Evidence X-ray crystallography of the archaeal Imp4/Brix ortholog Mil and structural comparison

   PMID:15654320

   Open questions at the time

   • Proposed RNA-binding surface not validated by mutagenesis
   • Structure of human BRIX1 itself not determined
   • No RNA-bound complex
5. 2021 Medium

   Placed BRIX1 within oncogenic signaling by identifying it as an AR-ERK-regulated effector controlling proliferation, apoptosis, and chemosensitivity in bladder cancer.

   Evidence DNA microarray, shRNA knockdown, pharmacological ERK activation, cisplatin sensitivity assays, and tissue immunohistochemistry

   PMID:33652650

   Open questions at the time

   • Did not connect chemoresistance phenotype to ribosome biogenesis function
   • Single-lab study
   • Mechanism linking AR-ERK to BRIX1 expression unresolved
6. 2024 High

   Linked BRIX1's ribosome biogenesis role to p53 control, showing it promotes PeBoW complex formation and suppresses nucleolar-stress p53 activation by blocking MDM2-RPL5/RPL11 interactions.

   Evidence siRNA knockdown, reciprocal Co-IP, p53 reporter assays, and xenograft models with siBRIX1-loaded engineered exosomes

   PMID:39475053

   Open questions at the time

   • Direct binding interface mediating MDM2-RPL5/RPL11 disruption not mapped
   • Whether the effect is direct or secondary to ribosome stress unresolved
7. 2024 Medium

   Demonstrated that BRIX1 couples ribosome biogenesis to tumor metabolism via selective translational upregulation of GLUT1, driving glycolysis.

   Evidence Knockdown/overexpression, rRNA and nascent RNA quantification, polysome fractionation, metabolic flux (ECAR/OCR), and orthotopic tumor model

   PMID:38282151

   Open questions at the time

   • Mechanism of GLUT1 mRNA translational selectivity not defined
   • Single-lab study
8. 2025 High

   Integrated BRIX1 into a transcription-to-splicing axis, showing it is induced by mTORC1-SP1, drives rDNA transcription with UBTF/POLR1A, and sustains SRSF1-mediated oncogenic splicing feeding mTORC1 signaling.

   Evidence ChIP-PCR, Co-IP/MS, EU RNA synthesis and puromycin incorporation assays, RNA-seq with isoform qRT-PCR, and SRSF1 rescue

   PMID:41370029

   Open questions at the time

   • Whether BRIX1 regulates SRSF1 directly or via translation not fully resolved
   • Direct vs. assembly-cofactor role at UBTF/POLR1A interaction unclear

• How the conserved 60S-assembly activity of BRIX1 mechanistically gives rise to its diverse oncogenic outputs (p53 buffering, GLUT1 translation, SRSF1 splicing) remains unresolved.
• No structure of human BRIX1 bound to rRNA or partners
• Causal hierarchy between ribosome biogenesis defect and downstream phenotypes not dissected
• Whether oncogenic functions are separable from core biogenesis role unknown